Literature DB >> 7365173

Psychiatric findings in the population of a geriatric evaluation unit: implications.

K C Cheah, O W Beard.   

Abstract

Psychiatric evaluation was performed routinely in 262 patients newly admitted to a Medical Geriatric Evaluation Unit (GEU). The study was conducted in a medical facility that provides excellent medical and surgical care for acute illnesses. The psychiatric disorders found far exceeded those one might expect in a comparable general population, and most were not recognized prior to the patient's transfer. For example, in the GEU, the incidence of organic brain syndrome was 65.3 percent, and of dysphoria-depression 31.3 percent. The data indicate a need to recognize psychiatric problems in order to ensure appropriate care, and suggest that medical care of the elderly with acute illness will be inadequate if it is based upon the approach used for younger populations. This situation apparently exists in most hospitals, including leading medical centers. The needs of the elderly with acute illnesses are quite different from those of younger patients. Recognition of factors that potentially influence outcomes and overall future health will meet public health's primary and secondary prevention goals.

Entities:  

Mesh:

Year:  1980        PMID: 7365173     DOI: 10.1111/j.1532-5415.1980.tb00508.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  3 in total

1.  Determinants of recovery 12 months after hip fracture: the importance of psychosocial factors.

Authors:  J M Mossey; E Mutran; K Knott; R Craik
Journal:  Am J Public Health       Date:  1989-03       Impact factor: 9.308

Review 2.  Functional assessment as a model for clinical evaluation of geriatric patients.

Authors:  R W Besdine
Journal:  Public Health Rep       Date:  1988 Sep-Oct       Impact factor: 2.792

3.  Late-life depression in primary care. How well are we doing?

Authors:  D A Banazak
Journal:  J Gen Intern Med       Date:  1996-03       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.